VVOS — Vivos Therapeutics Share News
0.000.00%
Last trade - 00:00- $4.80m
- $11.13m
- $17.44m
Brief: Vivos Therapeutics Q1 Net Income USD -3.864 Million
Vivos Therapeutics Inc expected to post a loss of 40 cents a share - Earnings Preview
Brief: Vivos Therapeutics Signs Definitive Agreement To Acquire Largest Sleep Center Operator In Nevada
Vivos Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Vivos Therapeutics Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Vivos Therapeutics Inc Files For Mixed Shelf Of Up To $50 Million – SEC Filing
Vivos Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Vivos Therapeutics Q3 Net Income USD -2.616 Million
Vivos Therapeutics Inc expected to post a loss of 61 cents a share - Earnings Preview
Brief: Vivos Therapeutics Prices $4.3 Mln Registered Direct Offering Of Common Stock
U.S. STOCKS ON THE MOVE-United States Steel, Ambac Financial, Apple
U.S. STOCKS ON THE MOVE-Powerfleet, NMI, Vivos Therapeutics
Vivos Therapeutics rises on FDA approval for pediatric sleep apnea device
Vivos Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Vivos Therapeutics Q2 Net Income USD -1.93 Million
Vivos Therapeutics Inc expected to post a loss of $1.05 a share - Earnings Preview
Brief: Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot